Age-related macular degeneration research hub

Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients

This study looks at a new scanning method to see how much activity there is in the eyes of people with a common eye condition called Age-related Macular Degeneration (AMD). We want to see if this scan can help doctors understand how well treatments are working.

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE

This study, called PINNACLE, looks into early changes in Age-related Macular Degeneration (AMD) before it gets worse. Researchers will track patients' eyes using special scans to understand how the disease develops. This helps scientists learn more, potentially leading to better ways to help people with AMD.

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

This study, SUMMIT, is a continuation of the PINNACLE study. It's for people with a common eye condition called Age-related Macular Degeneration (AMD) to understand how it progresses over time. We're looking for early changes that lead to advanced AMD.

Visual Frailty in Ageing

This study looks at 'visual frailty' in older people with a common eye condition called AMD. Researchers want to understand and measure how vision problems, general health, and mental well-being are linked, to help improve care for ageing eyes.

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

This study looks at a tiny telescope implant (SING IMT) for people with severe age-related macular degeneration (AMD). It aims to see if the implant is safe and helps improve blurry central vision, with patients receiving follow-up care and vision training for 12 months.

Photobiomodulation in Dry Age Related Macular Degeneration

This study is looking at whether yellow and red light treatment can help people with dry age-related macular degeneration (AMD). Researchers want to see if this light therapy can reduce deposits in the eye and improve vision. Participants will either receive the light treatment or a dummy treatment.

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

This study is looking at a new treatment called i-Lumen AMD, which uses a gentle electric current to help people with a common eye condition called Age-related Macular Degeneration (AMD). The aim is to see if it's safe and effective for slowing down the problem in the eyes.

Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression

This study looks at how a specific type of age-related macular degeneration (AMD) progresses. It uses AI and eye scans to understand changes over two years, aiming to personalize future monitoring for people with this AMD.

Retinal Pigment Epithelium Safety Study for Patients in B4711001

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

This study is testing a new medicine, Iptacopan, to see if it can stop or slow down age-related macular degeneration (AMD). Researchers are looking at people with early or intermediate AMD in one eye and a more advanced type in the other eye.

Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression

This study uses AI to better understand and predict how Age-Related Macular Degeneration (AMD) progresses. We want to find out why some people with early AMD develop advanced vision loss over two years and how to spot it sooner using eye scans.